Learnings from the Speedy Development of an mRNA-Based COVID-19 Vaccine

Time: 9:00 am
day: Day One


  • Discussing the viability of mRNA as an effective therapeutic modality
  • Sharing insights of mRNA therapies to employ for future rapid development of vaccines against other infectious diseases and future pandemics
  • With a streamlined process from pre-clinical candidates through to large-scale production, what are the essential elements for future mRNA-based efforts